Clover Health Investments, CORP /DE Form 4 insider transactions

Chelsea Clinton, a director of Clover Health Investments, reported the acquisition of 60,975 shares of Class A common stock on January 6, 2025, as part of a restricted stock unit award.

Demetrios L. Kouzoukas, a director at Clover Health Investments, Corp., acquired 60,975 shares of Class A Common Stock through a grant of restricted stock units.

Jamie Reynoso, CEO of Clover Health, disposed of shares to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary at Clover Health, reported a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health and an officer at Clover Health Investments, sold 98,217 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of shares to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary at Clover Health Investments, sold 7,444 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of 85,367 shares of Class A Common Stock on November 8, 2024, to cover tax obligations related to the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

CEO of Counterpart Health, Conrad Wai, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Clover Health CEO Jamie Reynoso sold 118,050 shares of Class A Common Stock on October 31, 2024, to cover tax obligations related to the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, sold 48,305 shares of Class A Common Stock on October 18, 2024, to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the acquisition of restricted stock units (RSUs) and changes in beneficial ownership of Class A Common Stock.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, reports acquiring shares of Class A Common Stock through a restricted stock unit award.

Brady Priest, CEO of Home Care at Clover Health, reports acquiring 726,114 shares of Class A Common Stock on October 15, 2024, resulting in a total beneficial ownership of 2,699,323 shares.

Conrad Wai, CEO of Counterpart Health (and officer of Clover Health Investments), acquired 726,114 shares of Class A Common Stock on October 15, 2024, bringing his total holdings to 3,578,246 shares.

Clover Health CEO Andrew Toy acquired 1,910,828 shares of Class A common stock through a restricted stock unit award on October 15, 2024.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, sold shares of Class A Common Stock to cover tax obligations arising from the vesting of restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, reports acquisition and disposal of Class A Common Stock related to vesting of restricted stock units.

Chief Technology Officer of Clover Health Investments, Conrad Wai, reports acquisition and disposal of Class A Common Stock related to vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the acquisition and disposal of Class A Common Stock related to vesting of restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, reports acquisition of shares through RSU vesting and subsequent withholding for tax obligations.

Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 5,241 shares of Class A Common Stock on August 14, 2024, to cover tax obligations related to vesting restricted stock units.

Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., purchased 531,700 shares of Class A Common Stock at an average price of $1.88 on August 9, 2024.

Aric Sharp, CEO of Value Based Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 32,416 shares of Class A Common Stock on July 18, 2024, to cover tax obligations related to vesting restricted stock units.